Your browser doesn't support javascript.
loading
Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis
Vidal, Mônica Scarpelli Martinelli; Castro, Luis Guilherme Martins de; Cavalecate, Sônia Cristina; Lacaz, Carlos da Silva.
  • Vidal, Mônica Scarpelli Martinelli; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Laboratório de Micologia Médica do Instituto de Medicina Tropical de São Paulo. São Paulo. BR
  • Castro, Luis Guilherme Martins de; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Clínica Dermatotológica. São Paulo. BR
  • Cavalecate, Sônia Cristina; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Laboratório de Micologia Médica do Instituto de Medicina Tropical de São Paulo. São Paulo. BR
  • Lacaz, Carlos da Silva; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Laboratório de Micologia Médica do Instituto de Medicina Tropical de São Paulo. São Paulo. BR
Rev. Inst. Med. Trop. Säo Paulo ; 45(6): 315-318, Nov.-Dec. 2003. ilus, tab
Article in English | LILACS | ID: lil-353981
RESUMO
Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by several dematiaceous fungi. The most commonly etiological agent found in Brazil is Fonsecaea pedrosoi, which appears as thick walled, brownish colored cells with transverse and longitudinal division in the lesions, called "muriform cells". This disease is found worldwide but countries like Madagascar and Brazil have highest incidence. Diagnosis is made by clinical, direct and histopathologic examination and culture of specimens. Serological tests have been used to identify specific antibodies against Fonsecaea pedrosoi antigens, as well as immunotechniques have been used for CBM serological identification and diagnosis. In the present study double immunodiffusion (DID), counterimmunoelectrophoresis (CIE) and immunoenzymatic test (ELISA) have been used to evaluate humoral immune response in patients with CBM caused by F. pedrosoi. Metabolic antigen was used for immunoprecipitation tests (DID and CIE) while somatic antigen for ELISA. Our results demonstrated 53 percent sensitivity and 96 percent specificity for DID, while CIE presented 68 percent sensitivity and 90.5 percent specificity. ELISA demonstrated 78 percent sensibility and 83 percent specificity. Serological tests can be a useful tool to study different aspects of CBM, such as helping differential diagnosis, when culture of the pathogenic agent is impossible.
Subject(s)
Full text: Available Index: LILACS (Americas) Main subject: Ascomycota / Chromoblastomycosis / Antibodies, Fungal Type of study: Diagnostic study / Observational study / Risk factors Limits: Humans Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2003 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Ascomycota / Chromoblastomycosis / Antibodies, Fungal Type of study: Diagnostic study / Observational study / Risk factors Limits: Humans Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2003 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR